Nanostics Inc. Their mission is to improve diagnostic accuracy and enhance healthcare decision-making through the integration of machine learning and extracellular vesicle detection. Led by an esteemed team of experts, including Dr.

John D. Lewis, Founder, Board Chair, and Chief Executive Officer, their leadership is driven by a passion for innovation and precision medicine. Dr.

Lewis, a renowned oncologist, has made significant contributions to cancer diagnostics and molecular imaging technologies. Nanostics offers a range of cutting-edge products and services that revolutionize healthcare. Their flagship product is the Nanostics diagnostics platform, developed and validated by lead researcher Dr.

Desmond Pink. This platform utilizes state-of-the-art machine learning models to provide accurate and reliable results for various medical conditions. The company's commitment to excellence is demonstrated through their collaborations with leading research institutions and their focus on regulatory compliance.

Nanostics is dedicated to transforming the future of healthcare by harnessing the power of technology to improve clinical outcomes and patient well-being